Net Income változás Dátum
AbbVie USD 822M 956M 2023-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Alnylam Pharmaceuticals USD -137870000 285.62M 2023-12
Amgen USD 767M 963M 2023-12
Arrowhead Research USD -132864000 23.18M 2023-12
Astellas Pharma JPY -1459000000 34.59B 2023-09
AstraZeneca USD 1.37B 444M 2023-09
Bayer EUR -4569000000 2.68B 2023-09
Biogen USD 249.7M 317.8M 2023-12
BioMarin Pharmaceutical USD 20.38M 20M 2023-12
Bluebird Bio USD -71731000 1.18M 2023-09
Bristol-Myers Squibb USD 1.76B 166M 2023-12
Daiichi Sankyo JPY 40B 17.02B 2023-09
Eli Lilly USD 2.19B 2.25B 2023-12
Exelixis USD 1.04M 80.14M 2023-09
Gilead Sciences USD 1.43B 751M 2023-12
GlaxoSmithKline GBP 1.46B 160M 2023-09
Incyte USD 201.08M 29.81M 2023-12
Ionis Pharmaceuticals USD -9263000 138.15M 2023-12
Merck USD -1226000000 5.97B 2023-12
Moderna USD 217M 3.85B 2023-12
Nektar Therapeutics USD -45837000 5.28M 2023-09
Novartis USD 1.76B 553M 2023-09
Pfizer USD -3368000000 986M 2023-12
Regeneron Pharmaceuticals USD 1.16B 151.8M 2023-12
Roche Holding CHF 7.14B 3.25B 2023-06
Sarepta Therapeutics USD -40937000 17M 2023-09
Vertex Pharmaceuticals USD 1.04B 119.6M 2023-09



Agios Pharmaceuticals Nettó Jövedelem - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.